drugset / Trial / NCT00757601
A Study to Test the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK1006 (MK-1006-002)(COMPLETED)
RandomizedCrossoverDouble-blindTreatment
Summary
This study will assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of MK1006
Timeline
- Start
- 2008-04
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MK-1006 | Unknown | 15 mg | — |
| Subject | MK-1006 | Unknown | 30 mg | — |
| Subject | MK-1006 | Unknown | 45 mg | — |
| Subject | MK-1006 | Unknown | 60 mg | — |
| Subject | MK-1006 | Unknown | 80 mg | — |
| Subject | MK-1006 | Unknown | 100 mg | — |
| Subject | MK-1006 | Unknown | 120 mg | — |
| Subject | MK-1006 | Unknown | 140 mg | — |
| Subject | MK-1006 | Unknown | 170 mg | — |
| Subject | MK-1006 | Unknown | 200 mg | — |
| Subject | MK-1006 | Unknown | 230 mg | — |
| Subject | MK-1006 | Unknown | 260 mg | — |